Exited
Exited: 1.36%
Scion Asset Management exited a position that was 1.36% of the portfolio, selling 15,000 shares.
Estimated quarter price range
Price estimate unavailable.
-15,000 Shares
Current: 0 Shares
-100.00%
Back to 13F signals
Unclassified
REGENERON PHARMACEUTICALS
Current managers
1
Company market cap
Unavailable
No reliable live market-cap source is available for this company.
Estimated quarter price range
Latest four quarters with available market data.
0
Q1 2026Price estimate unavailable.
Q4 2025Price estimate unavailable.
Q3 2025Price estimate unavailable.
Q2 2025Price estimate unavailable.
Price estimate unavailable.
Latest 13F signals for this stock
Counts show how tracked institutions changed this company in their latest available filings.
3
New position
0
Increased
0
Reduced
1
Exited
2
Who holds it and what changed this quarter
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
SEC11/03/2025
Exited
Exited: 0.00%
ARK Invest exited a position that was 0.00% of the portfolio, selling 110 shares.
Estimated quarter price range
Price estimate unavailable.
-110 Shares
Current: 0 Shares
-100.00%
Reduced
0.20% -> 0.08%
Bridgewater Associates sold 50,021 shares; portfolio weight moved from 0.20% to 0.08%.
Estimated quarter price range
Price estimate unavailable.
-50,021 Shares
-68.76%
SEC source transparency
Signals are derived from SEC EDGAR 13F information tables. Search aliases, tickers, themes, and company mappings help discovery but do not replace the original filing.
Data source
SEC EDGAR
Source filings
16
Latest reporting quarter
2026Q1
Four-quarter trend
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Related option rows are tracked separately
This common-stock page keeps CALL/PUT rows separate for accuracy. Related option rows: REGENERON PHARMACEUTICALS CALL.
Historical and source details
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
Quarterly holdings details
| Quarter | Current managers | Combined holding value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 3 | $61,242,888 | 116,653 | Bridgewater Associates New position - 89,047 Shares Scion Asset Management New position - 15,000 Shares ARK Invest New position - 12,606 Shares |
| Q3 2025 | 2 | $139,175,005 | 247,523 | Bridgewater Associates Increased - 235,381 Shares Scion Asset Management Exited - 0 Shares ARK Invest Reduced - 12,142 Shares |
| Q4 2025 | 2 | $56,234,334 | 72,855 | Bridgewater Associates Reduced - 72,745 Shares ARK Invest Reduced - 110 Shares |
| Q1 2026 | 1 | $17,557,471 | 22,724 | Bridgewater Associates Reduced - 22,724 Shares ARK Invest Exited - 0 Shares |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Holding market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Bridgewater Associates | REGENERON PHARMACEUTICALS | 75886F107 | COM | $17,557,471 | 22,724 | 0.08% | SEC XML |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.